Abstract
ABSTRACT: Nitric oxide (NO), an important vasodilatory modulator of systemic and pulmonary vascular tone, is synthesized from l-arginine by the enzyme NO synthase in vascular endothelial and smooth muscle cells. l-Arginine analogs, such as Nω -nitro-l-arginine methyl ester (l-NAME), are competitive antagonists of NO synthase and inhibit NO synthesis. Group B streptococcus (GBS) causes pulmonary hypertension, hypoxemia, lung vascular injury, and reduced cardiac output in both human newborns and neonatal piglets. Lung vascular injury associated with prolonged GBS infusion in piglets may attenuate NO production and thus promote severe pulmonary hypertension. We studied the effect of the NOS inhibitor, l-NAME and the precursor of NO, l-arginine, on pulmonary and systemic hemodynamics during late-phase GBS sepsis in the piglet model. Neonatal piglets were anesthetized, ventilated with room air, and randomized to receive a continuous infusion of saline (n=5) or GBS (n=5) for 4 h. After 3 h of infusion, both groups received a bolus of l-NAME (3 mg/kg). Hemodynamic and gas exchange indices were measured at baseline, 30 min, and 3 h of infusion, and 30 min and 1 h after l-NAME treatment. l-NAME treatment caused 1) significant increases in mean pulmonary arterial pressure, pulmonary vascular resistance, mean systemic arterial pressure, and systemic vascular resistance for both groups; 2) a similar percentage of increase in pulmonary vascular resistance for the two groups; 3) greater reduction in cardiac output and SV in the GBS compared with the control group; and 4) no significant alterations in arterial partial pressure of oxygen or the difference between alveolar and arterial partial pressure of oxygen for either group. l-Arginine Arginine (1 g/kg) infusion after 3 h of GBS infusion (n=3) caused no significant changes in any measured hemodynamic or gas-exchange variable. We conclude that 1) endogenous NO synthesis is ongoing during late-phase GBS-induced pulmonary hypertension in neonatal piglets, and 2) NO synthesis is not limited by the substrate l-arginine in this model. NO synthase inhibitors alone appear to be contraindicated in the treatment of neonatal GBS sepsis due to worsening pulmonary hypertension and progressive decline in cardiac output.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gibson, R., Berger, J., Redding, G. et al. Effect of Nitric Oxide Synthase Inhibition during Group B Streptococcal Sepsis in Neonatal Piglets. Pediatr Res 36, 776–783 (1994). https://doi.org/10.1203/00006450-199412000-00016
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199412000-00016